Open Access

Gelsolin impairs barrier function in pancreatic ductal epithelial cells by actin filament depolymerization in hypertriglyceridemia‑induced pancreatitis in vitro

  • Authors:
    • Hui-Ying Yang
    • Zhi-Hai Liang
    • Jin-Lian Xie
    • Qing Wu
    • Ying-Ying Qin
    • Shi-Yu Zhang
    • Guo-Du Tang
  • View Affiliations

  • Published online on: February 16, 2022     https://doi.org/10.3892/etm.2022.11219
  • Article Number: 290
  • Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

an sever actin filaments. Notably, actin dynamics affect the structure and function of epithelial barriers. The present study investigated the role of GSN in the barrier function of pancreatic ductal epithelial cells (PDECs) in hypertriglyceridemia‑induced pancreatitis (HTGP). The human PDEC cell line HPDE6‑C7 underwent GSN knockdown and was treated with caerulein (CAE) + triglycerides (TG). Intracellular calcium levels and the actin filament network were analyzed under a fluorescence microscope. The expression levels of GSN, E‑cadherin, nectin‑2, ZO‑1 and occludin were evaluated by reverse transcription‑quantitative polymerase chain reaction and western blotting. Ultrastructural changes in tight junctions were observed by transmission electron microscopy. Furthermore, the permeability of PDECs was analyzed by fluorescein isothiocyanate‑dextran fluorescence. The results revealed that CAE + TG increased intracellular calcium levels, actin filament depolymerization and GSN expression, and increased PDEC permeability by decreasing the expression levels of E‑cadherin, nectin‑2, ZO‑1 and occludin compared with the control. Moreover, changes in these markers, with the exception of intracellular calcium levels, were reversed by silencing GSN. In conclusion, GSN may disrupt barrier function in PDECs by causing actin filament depolymerization in HTGP in vitro.

Introduction

Severe hypertriglyceridemia (HTG) is the third major cause of acute pancreatitis (AP) after alcohol abuse and cholelithiasis worldwide (1). The severity and complication rates of HTG-induced pancreatitis (HTGP) are higher than those of AP that originate from other causes (2). The mechanism by which high triglyceride (TG) levels trigger AP is unknown (3), but may be due to the toxicity of free fatty acids (FFAs) to the pancreas. High concentrations of FFAs are generated from TG hydrolysis by lipases in pancreatic tissues and may trigger the self-digestion of the pancreas by damaging pancreatic acinar cells (PACs) and vascular endothelial cells, activating trypsinogen and protein kinase C, and releasing intracellular calcium (3,4).

Pancreatic ductal epithelial cells (PDECs) are considered the most important component of the pancreatic duct mucosal barrier, and serve a critical role in preventing the reflux of bile and pancreatic enzymes (5). Previous studies have reported that barrier disfunction in PDECs is a major contributor to the occurrence of pancreatitis (6-9). Our previous study revealed that the synthetic cholecystokinin analogue caerulein (CAE) induced AP in the human pancreatic ductal epithelial cell line HPDE6-C7(10). In addition, high-fat diet-derived FFAs can impair intestinal epithelial cell permeability (11-13); nonetheless, the effect of HTG on PDECs in AP is incompletely understood.

The cytoskeleton is a complex and dynamic system composed primarily of actin filaments, which is essential for key cellular functions, including adhesion, spreading, migration and interaction with the environment (14). Previous studies have reported that the maintenance of the endothelial barrier function and cell-cell junctions is critically dependent on actin filament dynamics (15-18), which are regulated by actin-binding proteins (ABPs) (19). Moreover, FFAs can modulate actin reorganization and have toxic effects on PACs by increasing cytosolic calcium concentrations (20-22), potentially leading to HTGP. However, to the best of our knowledge, the underlying mechanism of actin dynamics in PDECs in HTGP has not been explored.

Gelsolin (GSN) is a calcium-regulated ABP that controls actin dynamics by nucleating, capping and severing actin filaments, and participates in cell morphology, motility, metabolism, apoptosis and phagocytosis (23). Moreover, GSN has been reported to be involved in cell-cell junctions and can regulate cell adhesion strength by remodeling actin (24,25). Our unpublished data revealed that GSN is expressed in PDECs (HPDE6-C7) (Yang et al, unpublished data); however, the role of GSN in PDECs in HTGP is not fully understood.

The present study hypothesized that GSN may impair barrier function in PDECs by regulating actin filaments in HTGP. To test this hypothesis, GSN gene expression was knocked down and HTGP was induced using CAE (13) and TG in HPDE6-C7 cells, in order to assess the effect of GSN-regulated actin filaments on barrier function in PDECs in HTGP in vitro.

Materials and methods

Cell culture

The human PDEC line HPDE6-C7 (Guangzhou Jenniobio Biotechnology) was cultured in DMEM (Gibco; Thermo Fisher Scientific, Inc.) supplemented with 10% fetal bovine serum (Shanghai Shuangru Biotechnology Co., Ltd.), 1% L-glutamine (Beijing Solarbio Science & Technology Co., Ltd.) and 1% penicillin-streptomycin mixture (Beijing Solarbio Science & Technology Co., Ltd.) at 37˚C in a humidified atmosphere containing 5% CO2. Cells were grown on coverslips (24x24 mm) in 6-well plates or 25-cm2 flasks.

RNA interference-mediated GSN gene silencing

Three pairs of short hairpin RNA (shRNA) sequences were designed by BLOCK-iT™ RNAi Designer (Thermo Fisher Scientific Inc.) according to GSN coding DNA sequences and were synthesized by Sangon Biotech Co., Ltd. (Table I). The third generation lentiviral packaging system was used to inhibit GSN expression analysis. The shRNAs were cloned into the pcDNA6.2-GW/EmGFP-miR plasmid vector (Shanghai R&S Biotechnology Co., Ltd.). The cloned DNA fragments were amplified by PCR and subcloned into the pLenti6.3/V5-DEST vector (Shanghai R&S Biotechnology Co., Ltd.). A total of 60 µg lentiviral plasmids and ViraPower™ lentiviral packaging mix (Invitrogen; Thermo Fisher Scientific Inc.), mixed with POLOdeliverer™ 3000 Transfection Reagent (Shanghai R&S Biotechnology Co., Ltd.), were co-transfected into 293T cells (Shanghai R&S Biotechnology Co., Ltd.) in a 1:1 ratio. The transfected cells were incubated at 37˚C for 48 and 72 h, respectively, and the lentivirus supernatant was collected and concentrated. HPDE6-C7 cells were infected with lentivirus for 72 h, with a multiplicity of infection of 8. The lentivirus-infected cells derived from the third pairs of shRNAs were selected for subsequent experiments by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) screening and validation. The stable cell lines were created using 1.0 µg/ml blasticidin for selection and 0.5 µg/ml for maintenance. The lentivirus obtained from empty pLenti6.3/V5-DEST was used as an empty vector and HPDE6-C7 cells transduced with an empty vector were used as the negative control (NC).

Table I

Short hairpin RNA sequences used for GSN silencing.

Table I

Short hairpin RNA sequences used for GSN silencing.

NameOligonucleotide sequence (5'-3')
GSN-1F: TGCTGAAGAAGTCTCCATAAAGGTTGGTTTTGGCCACTGACTGACCAACCTTTGGAGACTTCTT
 R: CCTGAAGAAGTCTCCAAAGGTTGGTCAGTCAGTGGCCAAAACCAACCTTTATGGAGACTTCTTC
GSN-2F: TGCTGAGAACTGTCCATATGTGGCAGGTTTTGGCCACTGACTGACCTGCCACATGGACAGTTCT
 R: CCTGAGAACTGTCCATGTGGCAGGTCAGTCAGTGGCCAAAACCTGCCACATATGGACAGTTCTC
GSN-3F: TGCTGTACAGAATGATGTAGCTGTCGGTTTTGGCCACTGACTGACCGACAGCTATCATTCTGTA
 R: CCTGTACAGAATGATAGCTGTCGGTCAGTCAGTGGCCAAAACCGACAGCTACATCATTCTGTAC

[i] F, forward; GSN, gelsolin; R, reverse. Underlined text indicates effective RNA interference target sequences.

Cell treatment and experimental grouping

Cells with or without GSN silencing were treated with 100 nM CAE (MilliporeSigma), 2.5 mM TG (cat. no. T9420; Beijing Solarbio Science & Technology Co., Ltd.), or CAE + TG for 24 h at 37˚C. CAE was resuspended in phosphate-buffered saline (PBS), and TG was resuspended in PBS containing 0.1 mg/ml bovine serum albumin (cat. no. A8020; Beijing Solarbio Science & Technology Co., Ltd.). AP was induced in vitro using CAE, the effects of HTG on PDECs were assessed using TG, and HTGP was induced by CAE + TG. Cells were divided into 12 groups, as follows: Blank control (BC) group, cells without lentiviral transduction; CAE-treated BC group (CAE group); TG-treated BC group (TG group); CAE + TG-treated BC group (CAE + TG group); NC group, cells transduced with an empty vector; CAE-treated NC group (NC + CAE group); TG-treated NC group (NC + TG group); CAE + TG-treated NC group (NC + CAE + TG group); knockdown (KD) group, cells with GSN KD; CAE-treated KD group (KD + CAE group); TG-treated KD group (KD + TG group); and CAE + TG-treated KD group (KD + CAE + TG group).

Inverted biological microscopy analysis of cell morphology

Cells at a density of 4x105 cells/well were seeded into a six-well plate and cultured at 37˚C in a humidified atmosphere containing 5% CO2 until they reached 75-80% confluence. Then the cells were treated with purified trilaurin (TG; cat. no. T9420; Beijing Solarbio Science & Technology Co., Ltd.) at concentrations of 0.5, 1.0, 2.5, 5 and 10 mM for 24 h at 37˚C. Cell morphology was analyzed by an inverted biological microscopy (CKX53; Olympus Corporation) at x100 magnification.

Cell Counting Kit-8 (CCK-8) assay

Cell viability was determined using CCK-8 (cat. no. CA1210; Beijing Solarbio Science & Technology Co., Ltd.) according to the manufacturer's protocols. HPDE6-C7 cells at a density of 1x104 cells/well were seeded into a 96-well plate with 100 µl growth medium/well and cultured for 12 h. Subsequently, the cells were treated with TG (10 µl/well) at concentrations of 0.5, 1.0, 2.5, 5.0 and 10 mM for 24 h at 37˚C and 10 µl CCK-8 reagent was added to each well for 1 h at 37˚C. The absorbance was measured at 450 nm using a microplate reader (Varioskan LUX; Thermo Fisher Scientific Inc.).

DAPI staining

The cells were seeded into a 6-well plate at a density of 1x105 cells/well and cultured for 24 h, then treated with 100 nM CAE for 6, 12, 24 and 48 h or TG at concentrations of 0.5, 1.0, 2.5, 5.0 and 10 mM for 24 h at 37˚C. Subsequently, the cells were fixed in 4% paraformaldehyde (cat. no. P1110; Beijing Solarbio Science & Technology Co., Ltd.) for 30 min and stained with 100 µl DAPI solution (10 µg/ml; cat. no. C0065; Beijing Solarbio Science & Technology Co., Ltd.) in the dark for 5 min (all steps at room temperature). The cell nuclei were imaged at 460-495 nm under a fluorescence microscope. The cells stained light blue represented the DAPI positively stained cells.

Measurement of intracellular calcium

HPDE6-C7 cells were grown on 60-mm culture dishes until they reached 60-65% confluence. The cells were then washed three times with Hanks' balanced salt solution without calcium, magnesium and phenol red (cat. no. H1046; Beijing Solarbio Science & Technology Co., Ltd.) and were stained with Calcium Crimson (5 µM; 1.0 ml/dish; cat. no. C3018; Invitrogen; Thermo Fisher Scientific, Inc.) at 37˚C for 30 min in the dark. Subsequently, cells were washed with D-HBSS three times and stained with Hoechst 33258 (30 µg/ml; 1.0 ml/dish; cat. no. H3569; Invitrogen; Thermo Fisher Scientific, Inc.) at 37˚C for 20 min in the dark. Fluorescence in the cytosol and nucleus were measured at 530-550 and 460-495 nm, respectively, under an inverted fluorescence microscope (IX71; Olympus Corporation). Images were analyzed using ImageJ software (version 1.8.0; National Institutes of Health).

Transmission electron microscopy (TEM)

Control and GSN-silenced HPDE6-C7 cells were cultured in 25-cm2 flasks until they reached 70-80% confluence. Cells were harvested using a cell scraper, centrifuged at 1,500 x g for 10 min at room temperature, fixed in 3% glutaraldehyde for 2.5 h at 4˚C and washed three times with PBS (10 mM; 10 min/wash). Subsequently, the samples were fixed in 1% osmium for 2 h at 4˚C, washed three times with PBS (10 min/wash), dehydrated through a graded ethanol series, embedded in epoxy resin at 37˚C overnight. Epoxy resin samples were heated at 35˚C for 12 h, 45˚C for 15 h and 60˚C for 24 h, successively, cut into 70-nm sections and stained with 3% uranium acetate-lead citrate. Ultrastructural changes in tight junctions (TJs) were analyzed using TEM (Hitachi, Ltd.).

Western blotting

Proteins were lysed from HPDE6-C7 cells using RIPA buffer (Beijing Solarbio Science & Technology Co., Ltd.) containing 1% phenylmethyl sulfonyl fluoride (Beijing Solarbio Science & Technology Co., Ltd.) on ice for 30 min, and were centrifuged at 12,000 x g for 20 min at 4˚C. Protein concentration was determined using a bicinchoninic acid protein assay kit (cat. no. P0012; Beyotime Institute of Biotechnology). Proteins samples (50 µg/well) were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrotransferred to polyvinylidene fluoride membranes. Membranes were then blocked with 5% non-fat milk for 1 h at room temperature and incubated with primary antibodies against GSN (1:1,000; cat. no. ab74420; Abcam), ZO-1 (1:1,000; cat. no. 21173-1-AP; Wuhan Sanying Biotechnology), nectin-2 (1:1,000; cat. no. ab135246; Abcam), E-cadherin (1:1,000; cat. no. 20874-1-AP; Wuhan Sanying Biotechnology), occludin (1:1,000; cat. no. 27260-1-AP; Wuhan Sanying Biotechnology) and GAPDH (1:10,000; cat. no. ab181602; Abcam) overnight at 4˚C. Subsequently, membranes were incubated with DyLight 680-conjugated secondary anti-rabbit antibody (1:10,000; cat. no. 5366; Cell Signaling Technology, Inc.) for 1 h at room temperature in the dark. Immunoreactive bands were imaged using the Odyssey infrared imaging system (LI-COR Biosciences) and fluorescence intensity was semi-quantified using ImageJ software (version 1.8.0; National Institutes of Health).

RT-qPCR

Total RNA was isolated from HPDE6-C7 cells using RNAiso Plus (cat. no. 9108; Takara Bio, Inc.) and converted to cDNA by RT using PrimeScript RT reagent kit with gDNA Eraser (cat. no. RR047B; Takara Bio, Inc.) according to manufacturer's protocol. qPCR was performed using TB Green Premix Ex Taq II (cat. no. RR820B; Takara Bio, Inc.) and corresponding primers (Table II). The thermocycling conditions were as follows: Pre-denaturation at 95˚C for 30 sec, followed by 40 cycles of denaturation at 95˚C for 5 sec, annealing and extension at 60˚C for 34 sec. GAPDH was used as internal reference gene and the relative expression levels of target genes were measured using the 2-ΔΔCq method (26).

Table II

Target gene primers used in reverse transcription-quantitative polymerase chain reaction.

Table II

Target gene primers used in reverse transcription-quantitative polymerase chain reaction.

GeneForward primer (5'-3')Reverse primer (5'-3')
GAPDH ACATCGCTCAGACACCA GTAGTTGAGGTCAATGAAGGG
GSN AGCTGGCCAAGCTCTACAAG TGTTTGCCTGCTTGCCTTTC
E-cadherin AGGATGACACCCGGGACAAC TGCAGCTGGCTCAAGTCAAAG
Nectin-2 ACCTGCAAAGTGGAGCATGAGA CCGGAGATGGACACTTCAGGA
ZO-1 ATAAAGTGCTGGCTTGGTCTGTTTG GCACTGCCCACCCATCTGTA
Occludin AGTGCCACTTTGGCATTATGAGA CTTGTGGCAGCAATTGGAAAC

[i] GSN, gelsolin.

Immunofluorescence staining of actin filaments

Cells were plated onto coverslips (24x24 mm) in 6-well plates until they reached 55-60% confluence. The cells were fixed in 4% paraformaldehyde for 15 min at room temperature, permeabilized in 0.1% Triton X-100 for 5 min at room temperature, blocked in PBS containing 2% bovine serum albumin for 20 min at room temperature and stained with tetramethyl rhodamine isothiocyanate-phalloidin (100 nM; 50 µl/well; Beijing Solarbio Science & Technology Co., Ltd.) for 30 min at room temperature in the dark. The samples were washed with PBS three times at 5-min intervals between each step and mounted with anti-fading medium containing DAPI (cat. no. S2100; Beijing Solarbio Science & Technology Co., Ltd.) for 3 min at room temperature in the dark. Actin filaments were observed at 530-550 nm and cell nuclei were observed at 460-495 nm under an upright fluorescence microscope (BX53; Olympus Corporation).

Fluorescein isothiocyanate (FITC)-dextran fluorescence

HPDE6-C7 cell suspensions (2x105 cells/well) were cultured on microporous polycarbonate membranes (pore size, 0.4 µm) until they reached 100% confluence in the upper compartment of 12-well Transwell plates (cat. no. 3401; Corning, Inc.). The culture medium in the upper compartment was removed and adhered cells were washed with PBS twice. Subsequently, FITC-dextran (4 kDa; 0.5 mg/ml; 500 µl/well; MilliporeSigma) was added to the upper compartment, and PBS (1 ml/well) was added to the lower compartment. The plates were incubated in the dark for 60 min at 37˚C. Fluorescence in the lower compartment was measured using a microplate reader (excitation, 495 nm; emission, 520 nm; Thermo Fisher Scientific, Inc.) and quantified using a calibration curve of FITC-dextran.

Statistical analysis

Data are presented as the mean ± standard deviation and the experiments were repeated at least three times. Statistical analysis was performed by one-way analysis of variance and Tukey's post hoc test using SPSS Statistics version 22.0 (IBM Corp.), GraphPad Prism version 6.0 (GraphPad Software, Inc.) and ImageJ (version 1.8.0; National Institutes of Health). P<0.05 was considered to indicate a statistically significant difference.

Results

Effect of TG on cell viability and cell-cell junctions of PDECs

Cell viability and cell apoptosis of PDECs treated with TG (0.5, 1.0, 2.5, 5.0 and 10 mM) for 24 h were assessed by light microscope, CCK-8 assay and DAPI staining. The optimal TG intervention concentration was selected and its effects on cell-cell junctions was analyzed by TEM. The results showed that high levels of TG (≥2.5 mM) significantly inhibited cell viability (Fig. S1A and B) and increased cell apoptosis of PDECs (Fig. S1C). Therefore, 2.5 mM of TG was selected for subsequent experiments. Moreover, the analysis of cell-cell junctions showed that CAE and CAE + TG disrupted cell-cell junctions, particularly TJs, compared with the control. In addition, the disruptions were more pronounced with CAE + TG, but TG had no effect on cell-cell junctions compared with the control (Fig. S2).

Effect of intracellular calcium levels on GSN expression in HPDE6-C7 cells treated with CAE and TG

Intracellular calcium was semi-quantified by fluorescence microscopy, and changes in GSN gene and protein expression levels in HPDE6-C7 cells treated with CAE and TG were analyzed by RT-qPCR and western blotting. The results revealed that CAE and CAE + TG, as treatments of the BC and NC groups, increased intracellular calcium levels (Fig. 1A and B) and the mRNA and protein expression levels of GSN relative to baseline (Fig. 1C-E), and the increase was more pronounced with CAE + TG. Notably, as treatment of the BC and NC groups, TG had no detectable effect on intracellular calcium levels (Fig. 1A and B) and GSN expression (Fig. 1C-E). Moreover, GSN silencing in the KD + CAE and KD + CAE + TG groups did not affect intracellular calcium levels compared with the NC + CAE and NC + CAE + TG groups (Fig. 1A and B), and lentiviral-mediated RNA interference in the KD group significantly reduced the mRNA and protein expression of GSN in PDECs compared with the NC group (Fig. 1C-E).

Effect of GSN on actin filament dynamics in HPDE6-C7 cells treated with CAE and TG

Changes in actin filament dynamics by GSN silencing were analyzed by immunofluorescence. The results demonstrated that CAE and CAE + TG, as treatments of the BC and NC groups, disrupted the actin filament network, and the effect was stronger with CAE + TG, whereas GSN silencing reduced this effect in the comparisons of the NC + CAE and KD + CAE groups or the NC + CAE + TG and KD + CAE + TG groups. Notably, TG, as treatment of the BC and NC groups, did not cause actin depolymerization (Fig. 2).

Effect of GSN on the major components of cell-cell junctions in HPDE6-C7 cells treated with CAE and TG

The expression levels of major components of cell-cell junctions, including E-cadherin, nectin-2, ZO-1 and occludin, were analyzed by RT-qPCR and western blotting. The results revealed that CAE and CAE + TG, as treatments of the BC and NC groups, reduced the mRNA (Fig. 3A-D) and protein (Fig. 3E-I) expression levels of these markers relative to baseline. Conversely, GSN silencing reduced the effects of CAE and CAE + TG treatment in the comparisons of the NC + CAE and KD + CAE groups or the NC + CAE + TG and KD + CAE + TG groups (Fig. 3).

Effect of GSN on TJ ultrastructure and permeability of HPDE6-C7 cells treated with CAE and TG

The ultrastructure of TJs in HPDE6-C7 cells was evaluated by TEM. The present study revealed that treatment with CAE and CAE + TG, as treatments of the BC and NC groups, decreased the number of TJ strands and disrupted the organization of cell-cell junctions; some cells in the CAE + TG and NC + CAE + TG groups had no TJs. GSN silencing mitigated the effects of CAE and CAE + TG treatment in the comparisons of the NC + CAE and KD + CAE groups or the NC + CAE + TG and KD + CAE + TG groups (Fig. 4A). In addition, CAE + TG, as treatment of the BC and NC groups, increased cell permeability more strongly than CAE, and GSN silencing attenuated this effect in the comparisons of the NC + CAE and KD + CAE groups or the NC + CAE + TG and KD + CAE + TG groups, whereas TG, as treatment of the BC and NC groups, alone did not affect cell permeability (Fig. 4B).

Time-dependent effects of CAE on apoptosis, GSN protein expression and actin filament dynamics in HPDE6-C7 cells

HPDE6-C7 cells were treated with CAE for 6, 12, 24 and 48 h. Apoptosis was evaluated using DAPI staining under a fluorescence microscope, the protein expression of GSN was semi-quantified using western blotting, and actin filaments were analyzed by immunofluorescence. The results showed that CAE increased apoptosis (Fig. S3A), GSN protein expression (Fig. S3B and C) and actin filament depolymerization (Fig. S3D) in a time-dependent manner in HPDE6-C7 cells compared with the control.

Discussion

Previous studies have shown that the disruption of TJs and adherens junctions, which maintain the integrity and function of the endothelial barrier in PDECs, serves an important role in the pathogenesis of AP (27,28). Our data showed that CAE + TG disrupted cell-cell junctions of PDECs more compared with CAE, suggesting that the impairment of barrier structure of PDECs was more pronounced in HTGP compared with in AP. In addition, actin filament dynamics are associated with the maintenance of barrier integrity in PDECs (29). Furthermore, GSN has a pivotal role in controlling the actin filament network (30). The results of the present study showed that the protein expression of GSN increased, actin filaments depolymerized and the barrier function of PDECs disrupted in an in vitro model of HTGP. Moreover, GSN silencing reduced actin filament depolymerization and barrier disruption in these cells. These data confirmed that GSN may impair barrier function in PDECs in vitro by causing the depolymerization of actin filaments in HTGP.

Calcium overload in PACs is a significant contributor to AP and also occurs in HTGP (31). GSN is a calcium-sensitive modulator of actin filament length (23); however, to the best of our knowledge, the occurrence of calcium overload and its potential association with GSN in PDECs in HTGP has not been determined. In the present study, CAE + TG increased intracellular calcium levels and GSN protein expression more strongly than CAE alone, indicating that calcium overload and GSN expression in PDECs were more pronounced in HTGP than in AP. Conversely, GSN gene silencing did not affect calcium levels, suggesting that GSN as a calcium-activated protein did not regulate calcium, which is consistent with the literature (23,32).

The rearrangement of the actin network can affect the interaction between actin and ABPs (33). The ABP GSN modulates actin filament structure (30). The present study revealed that the increase in GSN expression levels and the disruption of actin dynamics were more pronounced in HTGP than in AP, whereas this disruption was prevented by knocking down GSN, indicating that GSN may depolymerize actin filaments in HTGP.

The role of GSN in cell-cell junctions in PDECs is still unclear. The present data demonstrated that the protein expression levels of GSN were increased and the cell-cell junction protein expression was decreased in the PDEC model of HTGP, whereas GSN silencing increased the expression levels of cell-cell junction proteins, indicating that GSN regulated the expression of these proteins. In addition, it has been reported that actin interacts with multiple tight junction proteins, including ZO-1 and occluding (34), and adherens junction proteins, such as nectin and E-cadherin (35). Therefore, given the regulatory effect of GSN on actin in HTGP, it was hypothesized that GSN regulated the expression of cell-cell junction proteins via actin depolymerization. However, additional studies are required to elucidate the underlying mechanisms.

Endothelial barrier function depends on the interactions of cell-cell junction proteins with the actin filament network (36,37). However, to the best of our knowledge, the role of GSN in epithelial barrier function has only been studied in ischemic lung injury (38). The present results showed that the impairment of TJs in PDECs was more severe in HTGP than in AP, and was reduced by knocking down GSN, suggesting that GSN significantly contributed to the maintenance of TJs in these cells. Moreover, the increase in the permeability of PDECs was higher in HTGP than in AP, and this effect was reduced by GSN silencing. Therefore, considering the association between actin filaments and barrier function (18,39), it was hypothesized that GSN may increase cell permeability in HTGP by depolymerizing actin.

Several limitations exist in the current study and additional work is required. Firstly, it would be beneficial to also assess the effects of GSN overexpression to further verify the regulatory mechanism. Secondly, a preliminary time-dependent study of CAE was performed and it was revealed that CAE increased apoptosis, GSN protein expression and actin filament depolymerization in a time-dependent manner in HPDE6-C7 cells (Fig. S3). Our future work will assess the time-dependent effects of TG + CAE on barrier function and actin filaments in PDECs, and the role of GSN in this mechanism.

In conclusion, the present study indicated that GSN may impair barrier function in PDECs in HTGP in vitro, potentially by causing actin depolymerization. These findings provided evidence for GSN as a novel therapeutic target for barrier disruption in PDECs in HTGP.

Supplementary Material

Effect of TG on the viability and apoptosis of HPDE6-C7 cells. HPDE6-C7 cells were treated with TG (0.5, 1.0, 2.5, 5.0 and 10 mM) for 24 h. (A) Inverted biological microscopy was used to analyze morphological changes (x100 magnification). (B) Cell viability was determined using the CCK-8 assay. **P<0.01, ***P<0.001 vs. control. (C) Changes in cell nuclei stained with DAPI under a fluorescence microscope (x200 magnification). The experiments were repeated at least three times. Data are presented as the mean ± standard deviation. TG, triglycerides.
Ultrastructure of TJs in HPDE6-C7 cells treated with CAE and TG. HPDE6-C7 cells were treated with TG (2.5 mM), CAE (100 nM) or TG + CAE for 24 h. Ultrastructure of TJs was analyzed by transmission electron microscopy (x80,000 magnification, red arrows indicate TJs). The experiments were repeated at least three times. CAE, caerulein; TG, triglycerides; TJ, tight junction.
Time-dependent assessment of the effects of CAE on GSN expression, actin filaments and apoptosis in HPDE6-C7 cells. HPDE6-C7 cells were treated with CAE (100 nM) for 6, 12, 24 and 48 h. (A) Changes in cell nuclei stained with DAPI under a fluorescence microscope (x200 magnification). (B) Western blotting and (C) semi-quantification of GSN protein expression. (D) Changes in actin filaments, as determined by tetramethyl rhodamine isothiocyanate-phalloidin immunofluorescence under an upright fluorescence microscope (x1,000 magnification, white arrows indicate actin filaments). The experiments were repeated at least three times. Data are presented as the mean ± standard deviation. *P<0.05, **P<0.01. CAE, caerulein; GSN, gelsolin.

Acknowledgements

The authors would like to thank Mrs. Xiaomin Mo (Department of Electron Microscopy, Guangxi Medical University, Nanning, Guangxi, China) for her assistance in transmission electron microscopy.

Funding

Funding: The present study was supported by grants from the Guangxi Natural Science Foundation (grant no. 2018GXNSFBA281078) and the National Natural Science Foundation of China (grant no. 81970558).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

HYY was the main contributor to the research, performing experimental work, analyzing data and writing the manuscript. GDT and ZHL conceived and designed the study. JLX and QW designed experimental procedures and performed cell culture. YYQ established an in vitro model of HTGP. SYZ performed lentiviral-mediated RNA interference and collected experimental data. HYY and GDT confirm the authenticity of all the raw data. All authors have read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

de Pretis N, Amodio A and Frulloni L: Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management. United European Gastroenterol J. 6:649–655. 2018.PubMed/NCBI View Article : Google Scholar

2 

Yang AL and McNabb-Baltar J: Hypertriglyceridemia and acute pancreatitis. Pancreatology. 20:795–800. 2020.PubMed/NCBI View Article : Google Scholar

3 

De Pretis N, De Marchi G and Frulloni L: Hypertriglyceridemic pancreatitis. Minerva Gastroenterol Dietol. 66:238–245. 2020.PubMed/NCBI View Article : Google Scholar

4 

Guo YY, Li HX, Zhang Y and He WH: Hypertriglyceridemia-induced acute pancreatitis: Progress on disease mechanisms and treatment modalities. Discov Med. 27:101–109. 2019.PubMed/NCBI

5 

Konok GP and Thompson AG: Pancreatic ductal mucosa as a protective barrier in the pathogenesis of pancreatitis. Am J Surg. 117:18–23. 1969.PubMed/NCBI View Article : Google Scholar

6 

Quilichini E, Fabre M, Dirami T, Stedman A, De Vas M, Ozguc O, Pasek RC, Cereghini S, Morillon L, Guerra C, et al: Pancreatic ductal deletion of Hnf1b disrupts exocrine homeostasis, leads to pancreatitis, and facilitates tumorigenesis. Cell Mol Gastroenterol Hepatol. 8:487–511. 2019.PubMed/NCBI View Article : Google Scholar

7 

Hayashi M and Novak I: Molecular basis of potassium channels in pancreatic duct epithelial cells. Channels (Austin). 7:432–441. 2013.PubMed/NCBI View Article : Google Scholar

8 

Ishiguro H, Yamamoto A, Nakakuki M, Yi L, Ishiguro M, Yamaguchi M, Kondo S and Mochimaru Y: Physiology and pathophysiology of bicarbonate secretion by pancreatic duct epithelium. Nagoya J Med Sci. 74:1–18. 2012.PubMed/NCBI

9 

Maléth J and Hegyi P: Calcium signaling in pancreatic ductal epithelial cells: An old friend and a nasty enemy. Cell Calcium. 55:337–345. 2014.PubMed/NCBI View Article : Google Scholar

10 

Wei B, Gong Y, Yang H, Zhou J, Su Z and Liang Z: Role of tumor necrosis factor receptor-associated factor 6 in pyroptosis during acute pancreatitis. Mol Med Rep. 24(848)2021.PubMed/NCBI View Article : Google Scholar

11 

Goldberg IJ, Cabodevilla AG, Samovski D, Cifarelli V, Basu D and Abumrad NA: Lipolytic enzymes and free fatty acids at the endothelial interface. Atherosclerosis. 329:1–8. 2021.PubMed/NCBI View Article : Google Scholar

12 

Su YR, Hong YP, Mei FC, Wang CY, Li M, Zhou Y, Zhao KL, Yu J and Wang WX: High-Fat diet aggravates the intestinal barrier injury via TLR4-rip3 pathway in a rat model of severe acute pancreatitis. Mediators Inflamm. 2019(2512687)2019.PubMed/NCBI View Article : Google Scholar

13 

Tanaka S, Nemoto Y, Takei Y, Morikawa R, Oshima S, Nagaishi T, Okamoto R, Tsuchiya K, Nakamura T, Stutte S and Watanabe M: High-fat diet-derived free fatty acids impair the intestinal immune system and increase sensitivity to intestinal epithelial damage. Biochem Biophys Res Commun. 522:971–977. 2020.PubMed/NCBI View Article : Google Scholar

14 

Svitkina TM: Ultrastructure of the actin cytoskeleton. Curr Opin Cell Biol. 54:1–8. 2018.PubMed/NCBI View Article : Google Scholar

15 

Van Itallie CM, Tietgens AJ, Krystofiak E, Kachar B and Anderson JM: A complex of ZO-1 and the BAR-domain protein TOCA-1 regulates actin assembly at the tight junction. Mol Biol Cell. 26:2769–2787. 2015.PubMed/NCBI View Article : Google Scholar

16 

Malinova TS and Huveneers S: Sensing of cytoskeletal forces by asymmetric adherens junctions. Trends Cell Biol. 28:328–341. 2018.PubMed/NCBI View Article : Google Scholar

17 

Yonemura S: Actin filament association at adherens junctions. J Med Invest. 64:14–19. 2017.PubMed/NCBI View Article : Google Scholar

18 

Shakhov AS, Dugina VB and Alieva IB: Structural features of actin cytoskeleton required for endotheliocyte barrier function. Biochemistry (Mosc). 84:358–369. 2019.PubMed/NCBI View Article : Google Scholar

19 

Pollard TD: Actin and actin-binding proteins. Cold Spring Harb Perspect Biol. 8(a018226)2016.PubMed/NCBI View Article : Google Scholar

20 

Petersen OH, Tepikin AV, Gerasimenko JV, Gerasimenko OV, Sutton R and Criddle DN: Fatty acids, alcohol and fatty acid ethyl esters: Toxic Ca2+ signal generation and pancreatitis. Cell Calcium. 45:634–642. 2009.PubMed/NCBI View Article : Google Scholar

21 

Bürgin-Maunder CS, Brooks PR and Russell FD: Omega-3 fatty acids modulate Weibel-Palade body degranulation and actin cytoskeleton rearrangement in PMA-stimulated human umbilical vein endothelial cells. Mar Drugs. 11:4435–4450. 2013.PubMed/NCBI View Article : Google Scholar

22 

Izadi M, Hou W, Qualmann B and Kessels MM: Direct effects of Ca2+/calmodulin on actin filament formation. Biochem Biophys Res Commun. 506:355–360. 2018.PubMed/NCBI View Article : Google Scholar

23 

Feldt J, Schicht M, Garreis F, Welss J, Schneider UW and Paulsen F: Structure, regulation and related diseases of the actin-binding protein gelsolin. Expert Rev Mol Med. 20(e7)2019.PubMed/NCBI View Article : Google Scholar

24 

Chan MW, El Sayegh TY, Arora PD, Laschinger CA, Overall CM, Morrison C and McCulloch CA: Regulation of intercellular adhesion strength in fibroblasts. J Biol Chem. 279:41047–41057. 2004.PubMed/NCBI View Article : Google Scholar

25 

Kim KM, Adyshev DM, Kása A, Zemskov EA, Kolosova IA, Csortos C and Verin AD: Putative protein partners for the human CPI-17 protein revealed by bacterial two-hybrid screening. Microvasc Res. 88:19–24. 2013.PubMed/NCBI View Article : Google Scholar

26 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

27 

Kojima T, Yamaguchi H, Ito T, Kyuno D, Kono T, Konno T and Sawada N: Tight junctions in human pancreatic duct epithelial cells. Tissue Barriers. 1(e24894)2013.PubMed/NCBI View Article : Google Scholar

28 

Naydenov NG, Baranwal S, Khan S, Feygin A, Gupta P and Ivanov AI: Novel mechanism of cytokine-induced disruption of epithelial barriers: Janus kinase and protein kinase D-dependent downregulation of junction protein expression. Tissue Barriers. 1(e25231)2013.PubMed/NCBI View Article : Google Scholar

29 

Sakakibara S, Maruo T, Miyata M, Mizutani K and Takai Y: Requirement of the F-actin-binding activity of l-afadin for enhancing the formation of adherens and tight junctions. Genes Cells. 23:185–199. 2018.PubMed/NCBI View Article : Google Scholar

30 

Lee M and Kang EH: Molecular dynamics study of interactions between polymorphic actin filaments and gelsolin segment-1. Proteins. 88:385–392. 2020.PubMed/NCBI View Article : Google Scholar

31 

Feng S, Wei Q, Hu Q, Huang X, Zhou X, Luo G, Deng M and Lü M: Research progress on the relationship between acute pancreatitis and calcium overload in acinar cells. Dig Dis Sci. 64:25–38. 2019.PubMed/NCBI View Article : Google Scholar

32 

Nag S, Larsson M, Robinson RC and Burtnick LD: Gelsolin: The tail of a molecular gymnast. Cytoskeleton (Hoboken). 70:360–384. 2013.PubMed/NCBI View Article : Google Scholar

33 

Kang B, Jo S, Baek J, Nakamura F, Hwang W and Lee H: Role of mechanical flow for actin network organization. Acta Biomater. 90:217–224. 2019.PubMed/NCBI View Article : Google Scholar

34 

Odenwald MA, Choi W, Buckley A, Shashikanth N, Joseph NE, Wang Y, Warren MH, Buschmann MM, Pavlyuk R, Hildebrand J, et al: ZO-1 interactions with F-actin and occludin direct epithelial polarization and single lumen specification in 3D culture. J Cell Sci. 130:243–259. 2017.PubMed/NCBI View Article : Google Scholar

35 

Troyanovsky RB, Indra I, Chen CS, Hong S and Troyanovsky SM: Cadherin controls nectin recruitment into adherens junctions by remodeling the actin cytoskeleton. J Cell Sci. 128:140–149. 2015.PubMed/NCBI View Article : Google Scholar

36 

McRae M, LaFratta LM, Nguyen BM, Paris JJ, Hauser KF and Conway DE: Characterization of cell-cell junction changes associated with the formation of a strong endothelial barrier. Tissue Barriers. 6(e1405774)2018.PubMed/NCBI View Article : Google Scholar

37 

Sluysmans S, Vasileva E, Spadaro D, Shah J, Rouaud F and Citi S: The role of apical cell-cell junctions and associated cytoskeleton in mechanotransduction. Biol Cell. 109:139–161. 2017.PubMed/NCBI View Article : Google Scholar

38 

Becker PM, Kazi AA, Wadgaonkar R, Pearse DB, Kwiatkowski D and Garcia JG: Pulmonary vascular permeability and ischemic injury in gelsolin-deficient mice. Am J Respir Cell Mol Biol. 28:478–484. 2003.PubMed/NCBI View Article : Google Scholar

39 

Bogatcheva NV and Verin AD: The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res. 76:202–207. 2008.PubMed/NCBI View Article : Google Scholar

Related Articles

Journal Cover

April-2022
Volume 23 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yang H, Liang Z, Xie J, Wu Q, Qin Y, Zhang S and Tang G: Gelsolin impairs barrier function in pancreatic ductal epithelial cells by actin filament depolymerization in hypertriglyceridemia‑induced pancreatitis <em>in vitro</em>. Exp Ther Med 23: 290, 2022.
APA
Yang, H., Liang, Z., Xie, J., Wu, Q., Qin, Y., Zhang, S., & Tang, G. (2022). Gelsolin impairs barrier function in pancreatic ductal epithelial cells by actin filament depolymerization in hypertriglyceridemia‑induced pancreatitis <em>in vitro</em>. Experimental and Therapeutic Medicine, 23, 290. https://doi.org/10.3892/etm.2022.11219
MLA
Yang, H., Liang, Z., Xie, J., Wu, Q., Qin, Y., Zhang, S., Tang, G."Gelsolin impairs barrier function in pancreatic ductal epithelial cells by actin filament depolymerization in hypertriglyceridemia‑induced pancreatitis <em>in vitro</em>". Experimental and Therapeutic Medicine 23.4 (2022): 290.
Chicago
Yang, H., Liang, Z., Xie, J., Wu, Q., Qin, Y., Zhang, S., Tang, G."Gelsolin impairs barrier function in pancreatic ductal epithelial cells by actin filament depolymerization in hypertriglyceridemia‑induced pancreatitis <em>in vitro</em>". Experimental and Therapeutic Medicine 23, no. 4 (2022): 290. https://doi.org/10.3892/etm.2022.11219